Related Experiment Videos
How does cisplatin alter DNA structure? A molecular mechanics study on double-stranded oligonucleotides
1Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques, Unité associée au CNRS no. 400, Université René Descartes, Paris, France.
Biophysical Chemistry
|April 1, 1990
Summary
Molecular modeling revealed that platinum cross-links in DNA double helices cause significant kinking and unwinding. These findings provide insights into DNA structure alterations induced by platinum-based anticancer drugs.
Area of Science:
- Structural biology
- Computational chemistry
- Molecular modeling
Background:
- Platinum-based drugs are widely used in cancer chemotherapy.
- These drugs form cross-links within DNA, altering its structure.
- Understanding these structural changes is crucial for drug efficacy.
Purpose of the Study:
- To generate molecular models of DNA decanucleotides with platinum cross-links.
- To investigate the structural consequences of cis-diammineplatinum(II) cross-linking on DNA.
- To compare computational models with experimental Nuclear Magnetic Resonance (NMR) data.
Main Methods:
- Molecular mechanics calculations were employed.
- Two distinct double-stranded decanucleotides with platinum-guanine cross-links were modeled.
- Model building was informed by existing NMR data.
Main Results:
- Multiple molecular models were generated for each decanucleotide (nine for duplex 1, eight for duplex 2).
- All models exhibited a kink of approximately 60 degrees in the double helix, bending towards the major groove.
- The DNA double helix was also found to be slightly unwound in the presence of the platinum cross-link.
Conclusions:
- cis-diammineplatinum(II) cross-links induce significant kinking and unwinding in DNA double helices.
- The base adjacent to the cross-linked guanine pair influences the resulting DNA conformation.
- These structural distortions are key to understanding the mechanism of platinum-based chemotherapy.